Fadd and Skp2 are possible downstream targets of RUNX1-EVI1

  • MAKI Kazuhiro
    Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
  • SUGITA Fusako
    Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
  • NAKAMURA Yuka
    Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
  • SASAKI Ko
    Department of Hematology and Oncology, Dokkyo Medical University School of Medicine
  • MITANI Kinuko
    Department of Hematology and Oncology, Dokkyo Medical University School of Medicine

この論文をさがす

収録刊行物

参考文献 (30)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ